Edge
Device Oncology
PDI 00899475002028
General payments
$150,964
Research payments
$91,500
Through program year 2025, $150,964 in general payments and $91,500 in research payments were reported against Edge (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $39,702 | 75 |
| 2024 | General | $17,661 | 69 |
| 2024 | Research | $91,500 | 1 |
| 2023 | General | $30,078 | 55 |
| 2022 | General | $45,217 | 153 |
| 2021 | General | $18,306 | 66 |
Breakdown
The top 5 of 37 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
418 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.